Page last updated: 2024-10-22

alendronate and Menopause

alendronate has been researched along with Menopause in 11 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research Excerpts

ExcerptRelevanceReference
"The study was designed to evaluate the relationship of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on salivary flow rate, saliva pH, and electrolytes."7.73The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. ( Gurgan, S; Gurgan, T; Yalçin, F, 2005)
"The study was designed to evaluate the relationship of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on salivary flow rate, saliva pH, and electrolytes."3.73The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva. ( Gurgan, S; Gurgan, T; Yalçin, F, 2005)
"Treatment with alendronate decreased both urinary markers of bone resorption (pyridinolines, hydroxyproline, and calcium) and serum markers of bone formation (osteocalcin and alkaline phosphatase) in a dose-dependent fashion."2.67The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. ( Chesnut, CH; DeBrock, J; Eyre, DR; Genant, HK; Gertz, BJ; Harris, ST; Ricerca, E; Survill, TT; Ventura, JN, 1993)
"Many women now survive breast cancer, but find themselves at increased risk of menopausal complications."1.31Managing menopause after breast cancer: balancing risks and benefits. ( Moore, HC, 2001)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (27.27)18.2507
2000's5 (45.45)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Yoon, BK1
Citraro, R1
Gallelli, L1
Leo, A1
De Fazio, P1
Gallelli, P1
Russo, E1
De Sarro, G1
Lai, PS1
Chua, SS1
Chew, YY1
Chan, SP1
Fukunaga, M1
Toro, J1
Gentil, MA1
García, R1
Pérez-Valdivia, MA1
García Avellano, E1
Algarra, GR1
Pereira, P1
González-Roncero, F1
Mateos, J1
Yalçin, F1
Gurgan, S1
Gurgan, T1
d'Arailh, AS1
Lopes, P1
Harris, ST1
Gertz, BJ1
Genant, HK1
Eyre, DR1
Survill, TT1
Ventura, JN1
DeBrock, J1
Ricerca, E1
Chesnut, CH1
Bonde, M1
Garnero, P1
Fledelius, C1
Qvist, P1
Delmas, PD1
Christiansen, C1
Moore, HC1

Reviews

3 reviews available for alendronate and Menopause

ArticleYear
The impacts of menopausal hormone therapy on longer-term health consequences of ovarian hormone deficiency.
    Climacteric : the journal of the International Menopause Society, 2023, Volume: 26, Issue:3

    Topics: Alendronate; Estradiol; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Menopause; Pr

2023
[Bone mass measurement and evaluation of therapeutical response].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 2

    Topics: Absorptiometry, Photon; Aging; Alendronate; Biomarkers; Bone Density; Calcium; Estrogen Replacement

2004
[Menopause].
    La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16

    Topics: Age Factors; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Densitometry; Estrog

2006

Trials

4 trials available for alendronate and Menopause

ArticleYear
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:5

    Topics: Alendronate; Biomarkers, Pharmacological; Bone and Bones; Bone Density; Bone Density Conservation Ag

2011
Alendronate in kidney transplant patients: a single-center experience.
    Transplantation proceedings, 2005, Volume: 37, Issue:3

    Topics: Alendronate; Body Weight; Bone Density; Calcium; Female; Humans; Lumbar Vertebrae; Male; Menopause;

2005
The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:6

    Topics: Adult; Alendronate; Biomarkers; Blood; Bone Density; Bone Remodeling; Diphosphonates; Dose-Response

1993
New drugs for osteoporosis.
    The Medical letter on drugs and therapeutics, 1996, Jan-05, Volume: 38, Issue:965

    Topics: Administration, Intranasal; Aged; Alendronate; Calcitonin; Calcium; Costs and Cost Analysis; Delayed

1996

Other Studies

4 other studies available for alendronate and Menopause

ArticleYear
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model.
    Pharmacology, biochemistry, and behavior, 2015, Volume: 129

    Topics: Alendronate; Animals; Anxiety; Depression; Female; Menopause; Models, Animal; Rats; Rats, Wistar

2015
The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
    The journal of contemporary dental practice, 2005, May-15, Volume: 6, Issue:2

    Topics: Adult; Alendronate; Analysis of Variance; Bone Density Conservation Agents; Calcium; Case-Control St

2005
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1997, Volume: 12, Issue:7

    Topics: Adult; Alendronate; Amino Acid Sequence; Antibodies; Biomarkers; Bone Resorption; Collagen; Collagen

1997
Managing menopause after breast cancer: balancing risks and benefits.
    Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:3

    Topics: Adult; Alendronate; Antidepressive Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Calcit

2001